Shaw et al. [50] demonstrated that IL-1β, IL-6 and IL-8 improved the diagnostic performance of CA19-9 for discriminating PDAC from benign pancreatic diseases, jaundice, and chronic pancreatitis when they were in distinct panels with CA19-9, IP-10, and PDGF. This evidence concerns the gene IL6 and chronic pancreatitis.